| Home | Contact |
|
|
 eciphera has developed a suite of proprietary technologies for probing switch mechanisms in kinases, which control their shapes and biological activities. |
Deciphera's Pipeline |
 |
Home |
Fact Sheet |
Senior Management |
Board of Managers |
Scientific Advisory Board |
Platform |
Pipeline |
Oncology |
Metabolic
BCR-ABL | BRAF | News | Presentations | Careers | Location | Partners | Contact | Directions |
Copyright © Deciphera Pharmaceuticals,
LLC 2002-2009 |
